Acute leukemia: Diagnosis improved by flow cytometry in addition to morphology

Aims:  Immunophenotyping using flow cytometry (FCM) has become an essential component of acute leukemia (AL) diagnosis. This study evaluated the judicious application of FCM as an adjunct to well‐informed morpho‐cytochemical assessment in patients with acute leukemia.

[1]  R. Saxena,et al.  Flow cytometry in acute leukemia , 2008, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion.

[2]  J. H. Lee,et al.  Prognostic implications of the immunophenotype in biphenotypic acute leukemia , 2006, Leukemia & lymphoma.

[3]  C. Catoi,et al.  TUMORS OF HEMATOPOIETIC AND LYMPHOID TISSUES , 2007 .

[4]  Wafaa Y Bassuni,et al.  Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia. , 2006, Journal of the Egyptian National Cancer Institute.

[5]  D. Mitra,et al.  Polarized helper T cells in tubercular pleural effusion: phenotypic identity and selective recruitment , 2005, European journal of immunology.

[6]  E. Koay,et al.  Acute lymphoblastic leukemia with the phenotype of a putative B‐cell/T‐cell bipotential precursor , 2004, American journal of hematology.

[7]  X. Thomas,et al.  Adult T‐biphenotypic acute leukaemia: clinical and biological features and outcome , 2003, British journal of haematology.

[8]  R W McKenna,et al.  Multifaceted approach to the diagnosis and classification of acute leukemias. , 2000, Clinical chemistry.

[9]  C. Bloomfield,et al.  Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. , 1999, Blood.

[10]  D. Catovsky,et al.  Outcome of biphenotypic acute leukemia. , 1999, Haematologica.

[11]  R. Card,et al.  Biologic and clinical significance of CD7 expression in acute myeloid leukemia , 1998, American journal of hematology.

[12]  R. Consolini,et al.  Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. , 1998, Blood.

[13]  O. Legrand,et al.  Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P‐glycoprotein over‐expression , 1998, British journal of haematology.

[14]  Y. Matsuo,et al.  Flow cytometric diagnosis of the cell lineage and developmental stage of acute lymphoblastic leukemia by novel monoclonal antibodies specific to human pre-B-cell receptor. , 1998, Blood.

[15]  D. Neuberg,et al.  Expression of CD25 (interleukin-2 receptor α chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993 , 1997, Leukemia.

[16]  D. Catovsky,et al.  Definition of acute biphenotypic leukemia. , 1997, Haematologica.

[17]  D. Neuberg,et al.  Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group/Medical Research Council. , 1997, Leukemia.

[18]  L. Levitt,et al.  Biology and treatment of adult acute lymphoblastic leukemia. , 1996, The Western journal of medicine.

[19]  A Orfao,et al.  Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.

[20]  T. Fujimoto,et al.  Clinical significance of childhood acute myeloid leukemias expressing lymphoid-associated antigens. , 1995, Pediatric hematology and oncology.

[21]  S. Tura,et al.  The presence of lymphoid‐associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance , 1995, Stem cells.

[22]  G. Papa,et al.  Prognostic value of cell marker analysis in de novo acute myeloid leukemia. , 1994, Leukemia.

[23]  D. Catovsky,et al.  Lineage commitment in biphenotypic acute leukemia. , 1993, Leukemia.

[24]  M. Loken,et al.  CD45 Gating for Routine Flow Cytometric Analysis of Human Bone Marrow Specimens , 1993, Annals of the New York Academy of Sciences.

[25]  J. Krischer,et al.  Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  J. Griffin,et al.  Prognostic value of lymphocyte surface markers in acute myeloid leukemia. , 1991, Blood.

[27]  C. Hurwitz,et al.  Mixed-lineage leukemia and asynchronous antigen expression. , 1990, Hematology/oncology clinics of North America.

[28]  R. Bigler.  The Acute Leukemias: Biologic, Diagnostic, and Therapeutic Determinants , 1988 .

[29]  I Royston,et al.  Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. , 1987, The New England journal of medicine.

[30]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[31]  Robert J. Mayer,et al.  Surface marker anaylsis of acute myeloblastic leukemia: identifi- cation of differentiation-associated phenotypes. , 1983 .

[32]  H. Gralnick,et al.  Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.

[33]  J. Wolff,et al.  Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid. , 1948, The New England journal of medicine.